{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:14:04Z","timestamp":1745554444163},"reference-count":18,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The acute-on-chronic liver failure associated with hepatitis B virus (HBV-ACLF) was a type of clinical syndrome with rapid deterioration of liver function. It was characterized by short-term elevated bilirubin, ascites, prolonged clotting time, hepatic encephalopathy, organ failures, and high short-term mortality. It was important to predict and evaluate the disease early. This study intended to comprehensively analyze the prognostic factors of patients with ACLF associated with HBV DNA infection through clinical manifestations and laboratory tests, and to establish a corresponding prediction and evaluation model for further clinical guidance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 220 patients were first diagnosed with HBV-ACLF and admitted to and treated at the Department of Infectious Diseases of the First Affiliated Changhai Hospital of the Second Military Medical University from 2009 to 2018. These patients\u2019 records were collected and divided into two groups: (1) 120 patients who were improved and discharged were classified as good prognosis group and (2) 100 patients who died or underwent liver transplantation were classified as poor prognosis group. By analyzing baseline characteristics and clinical indicators of the two groups, the main potential factors affecting prognosis were identified and the corresponding prognostic evaluation model was established. This model\u2019s advantages and disadvantages were compared with classic prognostic scoring systems.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The proportion of ascites and the proportion of hepatic encephalopathy of poor prognosis group were significantly higher than those of good prognosis group. The total bilirubin, creatinine, white blood cell count, and NEU (%) levels of poor prognosis group were significantly higher than those of good prognosis group, and the international normalized ratio, albumin (ALB), alanine aminotransferase, Na, Cl, RBC, and PLT levels of poor prognosis group were significantly lower than those of good prognosis group. A new prediction model LR(<jats:italic>p<\/jats:italic>) = 1\/(1 + <jats:italic>e<\/jats:italic>\n                     <jats:sup>\u2212<jats:italic>Z<\/jats:italic>\n                     <\/jats:sup>) was established, where <jats:italic>z<\/jats:italic> = 10.0127 + 0.3687 \u00d7 NEUT (%) \u2212 0.0082 \u00d7 PLT + 1.8157 \u00d7 hepatic encephalopathy. The area under receiver operating characteristic (ROC) curve was 0.89, specificity was 80.83%, and sensitivity was 81%. The newly established prognostic model was compared with other three scoring systems including model for end-stage liver disease (MELD), MELD-Na, and ALBI scores. The results showed that the specificity, sensitivity, and area under the ROC curve of the newly established model were significantly higher than the other three scoring systems.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Hepatic encephalopathy, NEU (%), and PLT levels were independent risk factors for predicting the prognosis of HBV-ACLF. The new prediction model LR(<jats:italic>p<\/jats:italic>) had better prediction accuracy than the other three scoring models of MELD, MELD-Na, and ALBI and could more accurately assess the prognosis of HBV-ACLF, but in the later stage, it was still necessary to expand the sample size for verification.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/med-2020-0207","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T10:03:24Z","timestamp":1595930604000},"page":"714-722","source":"Crossref","is-referenced-by-count":3,"title":["Clinical prediction for outcomes of patients with acute-on-chronic liver failure associated with HBV infection: A new model establishment"],"prefix":"10.1515","volume":"15","author":[{"given":"Wenhan","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Changhai Hospital of The Second Military Medical University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Changhai Hospital of The Second Military Medical University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Luo","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, The Second Military Medical University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benming","family":"You","sequence":"additional","affiliation":[{"name":"Department of Medicinal Materials, The First Affiliated Changhai Hospital of The Second Military Medical University , Shanghai 200433 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Changhai Hospital of The Second Military Medical University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengzhong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Changhai Hospital of The Second Military Medical University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"2022052423224786592_j_med-2020-0207_ref_001_w2aab3b7d561b1b6b1ab2b1b1Aa","unstructured":"Liver Failure and Artificial Liver Group of Infectious Diseases Branch of Chinese Medical Association, Severe Hepatitis and Artificial Liver Group of Hepatology Association of Chinese Medical Association. Guidelines for diagnosis and treatment of liver failure (2012). Chin J Hepatol. 2013;21(3):177\u201383."},{"key":"2022052423224786592_j_med-2020-0207_ref_002_w2aab3b7d561b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426\u201337.","DOI":"10.1053\/j.gastro.2013.02.042"},{"key":"2022052423224786592_j_med-2020-0207_ref_003_w2aab3b7d561b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Garg H, Kumar A, Garg V, Sharma BC, Sarin SK. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis. 2012;44(2):166\u201371.","DOI":"10.1016\/j.dld.2011.08.029"},{"key":"2022052423224786592_j_med-2020-0207_ref_004_w2aab3b7d561b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, et al. Acute-on chronic liver failure. J Hepatol. 2012;57(6):1336\u201348.","DOI":"10.1016\/j.jhep.2012.06.026"},{"key":"2022052423224786592_j_med-2020-0207_ref_005_w2aab3b7d561b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Vaid A, Chweich H, Balk EM, Jaber BL. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO J. 2012;58(1):51\u20139. doi: 10.1097\/MAT.0b013e31823fd077.","DOI":"10.1097\/MAT.0b013e31823fd077"},{"key":"2022052423224786592_j_med-2020-0207_ref_006_w2aab3b7d561b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Shen Y, Wang XL, Wang B, Shao JG, Liu YM, Qin Y, et al. Survival benefits with artificial liver support system for acute-on-chronic liver failure: a time series-based meta-analysis. Medicine. 2016;95(3):e2506. doi: 10.1097\/MD.0000000000002506.","DOI":"10.1097\/MD.0000000000002506"},{"key":"2022052423224786592_j_med-2020-0207_ref_007_w2aab3b7d561b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Chen JJ, Huang JR, Yang Q, Xu XW, Liu XL, Hao SR, et al. Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure: a nationwide prospective multicenter study in China. Hepatobiliary Pancreat Dis Int. 2016;15(3):275\u201381. doi: 10.1016\/S1499-3872(16)60084-X.","DOI":"10.1016\/S1499-3872(16)60084-X"},{"key":"2022052423224786592_j_med-2020-0207_ref_008_w2aab3b7d561b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42(Suppl):S100\u20137, [PMID: 15777564. doi: 10.1016\/j.jhep.2004.11.015].","DOI":"10.1016\/j.jhep.2004.11.015"},{"key":"2022052423224786592_j_med-2020-0207_ref_009_w2aab3b7d561b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652\u201360.","DOI":"10.1053\/j.gastro.2006.02.010"},{"key":"2022052423224786592_j_med-2020-0207_ref_010_w2aab3b7d561b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Gao F, Sun L, Ye X, Liu Y, Liu H, Geng M, et al. Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure. Eur J Gastroenterol Hepatol. 2017;29(6):669\u201378.","DOI":"10.1097\/MEG.0000000000000854"},{"key":"2022052423224786592_j_med-2020-0207_ref_011_w2aab3b7d561b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Wu T, Li J, Shao L, Xin JJ, Jiang LY, Zhou Q, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67(12):2181\u201391.","DOI":"10.1136\/gutjnl-2017-314641"},{"key":"2022052423224786592_j_med-2020-0207_ref_012_w2aab3b7d561b1b6b1ab2b1c12Aa","unstructured":"Wang GQ, Wang FS, Chen J, et al. Guidelines for the prevention and treatment of chronic hepatitis B (2015). J Clin Hepatol. 2015;31(12):1941\u201360."},{"key":"2022052423224786592_j_med-2020-0207_ref_013_w2aab3b7d561b1b6b1ab2b1c13Aa","unstructured":"Liver Failure and Artificial Liver Group of Infectious Diseases Branch of Chinese Medical Association, Severe Hepatitis and Artificial Liver Group of Hepatology Association of Chinese Medical Association. Guidelines for diagnosis and treatment of liver failure (2012). J Pract Hepatol. 2013;16(3):210\u20136."},{"key":"2022052423224786592_j_med-2020-0207_ref_014_w2aab3b7d561b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464\u201370, [PMID: 11172350. doi: 10.1053\/jhep.2001.22172].","DOI":"10.1053\/jhep.2001.22172"},{"key":"2022052423224786592_j_med-2020-0207_ref_015_w2aab3b7d561b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, S Satomura, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u2009\u2013\u2009the ALBI grade. J Clin Oncol. 2015;33(6):550\u20138.","DOI":"10.1200\/JCO.2014.57.9151"},{"key":"2022052423224786592_j_med-2020-0207_ref_016_w2aab3b7d561b1b6b1ab2b1c16Aa","unstructured":"Li LJ, Duan ZP. Guidelines for diagnosis and treatment of liver failure (2012). Organ Transplant. 2013;21(4):210\u20136."},{"key":"2022052423224786592_j_med-2020-0207_ref_017_w2aab3b7d561b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine. 2017;96(24):e7142.","DOI":"10.1097\/MD.0000000000007142"},{"key":"2022052423224786592_j_med-2020-0207_ref_018_w2aab3b7d561b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Zou Z, Li B, Xu D, Zhang Z, Zhao JM, Zhou G, et al. Imbalanced intrahepatic cytokine expression of interferongamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on chronic liver failure associated with hepatitis B virus infection. J Clin Gastroenterol. 2009;43:182\u201390.","DOI":"10.1097\/MCG.0b013e3181624464"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/med\/15\/1\/article-p714.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2020-0207\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2020-0207\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T23:30:52Z","timestamp":1653435052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2020-0207\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,9,30]]},"published-print":{"date-parts":[[2020,9,30]]}},"alternative-id":["10.1515\/med-2020-0207"],"URL":"https:\/\/doi.org\/10.1515\/med-2020-0207","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}